Thoma Bravo-Backed LogRhythm Merges with Exabeam
The combined company will leverage the strengths from each organization aiming to take AI-driven security operations to new heights.
Source: themiddlemarket.com
📰 Goodwin Procter News
Page 3 - Goodwin Procter News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Goodwin Procter. Real-time updates on events, politics, business and more.
Pryor Cashman Wins 2024 Firm And Practitioner Of The Year From Managing IP - Management
Pryor Cashman won a pair of top prizes in the Managing IP Awards Americas 2024...
Source: mondaq.com
Subscription-Secured Credit Facilities: Recent Developments In The US Market And Considerations For Real Estate Funds - Fund Management/ REITs
Fund-level subscription-secured revolving lines of credit are a well-established instrument in the toolkits of a variety of private equity fund sponsors and managers...
Interplay Between Fund Credit Facilities Subscription Secured Credit Lines Real Estate Between Fund Credit Facilities Real Estate Specific Factors Goodwin Procter
Source: mondaq.com
WisdomTree Sends Letter to Stockholders Urging Full Support of the Current Board to Continue the Company's Strong Momentum | Region
NEW YORK--(BUSINESS WIRE)--May 6, 2024--
Source: eagletribune.com
Biglaw Firm's Outreach For Attorneys With ADHD
Goodwin is going out of their way to support employees with ADHD.
Garber Siegrist Elaine Ventola Carrie Garber Siegrist Casey Dixon Hazelden Betty Ford Foundation Lawyer Coaching Group
Source: abovethelaw.com
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Mariana Oncology a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer today announced it will be acquired by Novartis for 1 billion upfront and up to 750 million in potential milestone payments.
United States Chris Brinzey Goodwin Procter Biomedical Research At Novartis Atlas Venture Centerview Partners
Source: businesswireindia.com
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s...
Source: marketscreener.com
Kirkland hits Goodwin again for US funds lawyers
Four more lawyers join across US after quintet defected from Goodwin in Febraury
Source: globallegalpost.com
Ono Pharmaceutical : Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
Osaka, Japan and Waltham, Massachusetts, April 30, 2024 - ONO Pharmaceutical, Co., Ltd., and Deciphera Pharmaceuticals, Inc. today announced that on April 29, 2024 , ONO and Deciphera entered...
Source: marketscreener.com
Fresenius Kabi Announces Launch Of TYENNE, A Tocilizumab Biosimilar Referencing ACTEMRA - Life Sciences, Biotechnology & Nanotechnology
On April 15, 2024, Fresenius Kabi announced the U.S. launch of its ACTEMRA biosimilar, TYENNE (tocilizumab-aazg) as an intravenous formulation.
Source: mondaq.com